Sign Up to like & get recommendations! 2
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4722
Abstract: Anti‐PD1 checkpoint inhibitors (ICI) represent an established standard‐of‐care for patients with recurrent/metastatic head and neck squamous cell carcinoma (RMHNSCC). Landmark studies excluded patients with ECOG performance status (PS) ≥2; the benefit of ICI in this… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32645
Abstract: Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance status (PS). However, the benefit of ICIs for patients with a poor PS remains unknown. It… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer"
DOI: 10.1002/cncr.33238
Abstract: Patient‐reported outcomes have been used to assess treatment effectiveness and actively engage patients in their disease management. This study was designed to describe the patient‐reported performance status (PS) and the provider‐reported PS. read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28900
Abstract: Identification of patients with cirrhosis at risk for death within 3 months of discharge from the hospital is essential to individualize postdischarge plans. The objective of the study was to identify an easy‐to‐use prognostic model… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Hepatology"
DOI: 10.1002/hep.31124
Abstract: Identifying how the prognostic impact of performance status (PS) differs according to indication, era, and time period (“epoch”) after liver transplantation (LT) could have implications for selection and treatment of patients on the waitlist. We… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4621
Abstract: Immobilization osteoporosis is characterized by excess bone resorption. Vitamin D receptor activators (VDRA) might have adverse effects in immobilized patients. The objective of this study was to elucidate the impact of performance status (PS) on… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Surgery Today"
DOI: 10.1007/s00595-021-02303-8
Abstract: Deciding whether or not surgery should be performed for elderly patients is sometimes difficult. This study examined the prognosis of patients ≥ 80 years old with gastric cancer who underwent surgery or not. The medical records… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-020-06339-7
Abstract: Background The risk related to endoscopic retrograde cholangiopancreatography (ERCP) in patients with Eastern Cooperative Oncology Group performance status (PS) 4 is uncertain and remains a concern. Aims We aimed to examine the safety and efficacy… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-021-03712-y
Abstract: Poor Performance Status (PS) of cancer patients, defined as PS score 2–3, is an impediment for many drug- and irradiation-based treatments, supported by the trials that exclude subjects with PS read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Neurology and Neurosurgery"
DOI: 10.1016/j.clineuro.2017.11.016
Abstract: OBJECTIVES Maximal surgical resection of high grade brain tumours is associated with improved overall survival (OS). It carries the risk of neurological deterioration leading to worsening performance status (PS), which may affect overall survival and… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Endoscopy"
DOI: 10.1055/a-0924-5380
Abstract: A 74-year-old woman was hospitalized in August 2017 for altered performance status and obstructive cholangitis due to the recurrence of an adenocarcinoma involving the head of the pancreas that had been resected 2 year previously.… read more here.